|
Market Closed -
NYSE
21:00:02 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 80.84 USD | +1.00% |
|
-9.52% | +1.86% |
| 11-20 | UnitedHealth sues US government over lowered Medicare Advantage star ratings | RE |
| 11-20 | The 2018 bill that is rattling US insurers |
| Market Cap | 103B 94.21B 86.81B 78.96B 148B 9,578B 156B 1,056B 420B 5,231B 388B 380B 16,418B | P/E 2026 * |
11.5x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 157B 143B 131B 120B 224B 14,502B 236B 1,600B 636B 7,921B 588B 575B 24,859B | EV / Sales 2026 * |
0.37x | EV / Sales 2027 * | 0.35x |
| Free-Float |
71.21% | Yield 2026 * |
3.28% | Yield 2027 * | 3.37% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
| CVS | Real-time | ||
| CVS * | End-of-day quote | ||
| CVS | Real-time | ||
| 0HRS | Delayed | ||
| CVS | Real-time | ||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | End-of-day quote | ||
| CVS | End-of-day quote | ||
| CVSUS | End-of-day quote | ||
| 1CVS | End-of-day quote | ||
| CVSCL | End-of-day quote | ||
| 0HRS | Real-time | ||
| Real-time | |||
| CVS | Delayed | ||
| CVS | Delayed |
Last Transcript: CVS Health Corporation
| 1 day | +1.00% | ||
| 1 week | -9.52% | ||
| Current month | -10.43% | ||
| 1 month | -14.68% | ||
| 3 months | -13.68% | ||
| 6 months | -13.34% | ||
| Current year | +1.86% |
| 1 week | 78.98 | 90.71 | |
| 1 month | 77.33 | 94.84 | |
| Current year | 69.51 | 110.68 | |
| 1 year | 69.51 | 110.68 | |
| 3 years | 43.56 | 110.68 | |
| 5 years | 43.56 | 111.25 | |
| 10 years | 43.56 | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 16/10/2024 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 11/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 28/02/2007 |
Anne Finucane
BRD | Director/Board Member | 73 | 19/01/2011 |
| Director/Board Member | 71 | 04/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/11/26 | Buy | Executive/Senior Manager | 23,855 | 0.0019% | ||
| 31/05/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 31/05/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.00% | -9.52% | +6.31% | +18.43% | 103B | ||
| +3.31% | -4.70% | -0.15% | +91.45% | 99.34B | ||
| -5.70% | -14.32% | +21.21% | +399.00% | 39.62B | ||
| -0.73% | -0.48% | +14.07% | +94.82% | 31.77B | ||
| -0.47% | -0.90% | +40.41% | +73.91% | 29.81B | ||
| -0.31% | -0.51% | +37.67% | +91.53% | 28.42B | ||
| -0.15% | -7.99% | +40.98% | +305.22% | 20.95B | ||
| -0.62% | -2.67% | -15.69% | -20.65% | 19.39B | ||
| 0.00% | -0.38% | -2.83% | +32.77% | 16.97B | ||
| +5.29% | +7.91% | +23.94% | +68.07% | 14.29B | ||
| Average | +0.16% | -3.30% | +16.59% | +115.45% | 40B | |
| Weighted average by Cap. | +0.55% | -5.37% | +12.50% | +104.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 422B 384B 354B 322B 604B 39,081B 635B 4,311B 1,713B 21,346B 1,583B 1,550B 66,992B | 431B 393B 362B 329B 618B 39,950B 649B 4,407B 1,751B 21,820B 1,619B 1,585B 68,481B |
| Net income | 9B 8.19B 7.55B 6.87B 12.88B 833B 13.54B 91.88B 36.52B 455B 33.75B 33.04B 1,428B | 9.41B 8.57B 7.9B 7.18B 13.48B 871B 14.17B 96.13B 38.21B 476B 35.31B 34.57B 1,494B |
| Net Debt | 53.18B 48.43B 44.63B 40.6B 76.16B 4,924B 80.04B 543B 216B 2,690B 200B 195B 8,441B | 48.78B 44.43B 40.94B 37.24B 69.86B 4,517B 73.42B 498B 198B 2,467B 183B 179B 7,742B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | US$80.84 | +1.00% | 10,724,907 |
| 19/11/26 | US$80.04 | -1.61% | 15,944,964 |
| 18/11/26 | US$81.35 | -5.20% | 17,590,766 |
| 17/11/26 | US$85.81 | -3.14% | 13,620,793 |
| 16/11/26 | US$88.59 | -0.85% | 11,780,922 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions

















